Nuvation Bio股价因拟发行2亿美元可转债而下挫

路透中文06-25 22:16
BUZZ-<a href="https://laohu8.com/S/NUVB">Nuvation Bio</a>股价因拟发行2亿美元可转债而下挫

6月25日 - ** 癌症治疗公司Nuvation Bio（NUVB.N）股价周四下跌7.1%至6美元，其5连涨势头或将终结，该公司正寻求融资

** NUVB 宣布 (link) 公开发行2亿美元可转换债券，到期日为2032年

** 该公司计划将本次发行所得净收益用于全额偿还贷款协议，并用于一般用途，包括营运资金、运营支出和资本支出

** 此外，预计将动用部分募集资金支付“封顶看涨期权交易”的成本，以缓解潜在的股权稀释

** 杰富瑞、花旗集团和坎托菲茨杰拉德担任联合簿记管理人，加拿大皇家银行（RBC）参与承销

** 总部位于纽约市的NUVB市值约为20亿美元

** 受此影响，该股今年以来累计下跌33%

** 据LSEG数据显示，11位分析师的平均评级为“买入”，目标价中位数为12美元

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment